24 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
products, hire and retain skilled staff and key personnel, rely on third-party providers, protect its intellectual property and face litigation risk
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
results from pre-clinical and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
and clinical studies, successfully develop existing and new products, hire and retain skilled staff and key personnel, rely on third-party providers
6-K
EX-99.2
4vcu6he koorzffj
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.2
xla8qfvw8w
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
SUPPL
l3ghdksm
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
r4jldw2e3tck6k27ihl
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
EX-15.1
u4e t269uy
22 Jun 22
Annual report (foreign)
5:04pm
20-F
x00q l5yufdl
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.1
6mopr
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.3
smfdhifi
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.2
7le10b0bbpv9
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.2
t23dcd69q9jhp
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
EX-99.2
73eg6 g0t
13 Aug 21
Interim condensed consolidated financial statements of
7:10am
40-F
EX-99.3
ur2 zd4vzm0bt
28 May 21
Annual report (Canada)
12:12pm
40-F
EX-99.1
kowzaw lqrovb
28 May 21
Annual report (Canada)
12:12pm
6-K
EX-99.2
hn6n3rs0u3iewmnlej7
12 Feb 21
Interim condensed consolidated financial statements of
10:54am
SUPPL
1dsmfan2
30 Dec 20
Supplemental materials (foreign)
5:28pm